These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22473528)

  • 1. Contribution of the physicochemical properties of active pharmaceutical ingredients to tablet properties identified by ensemble artificial neural networks and Kohonen's self-organizing maps.
    Onuki Y; Kawai S; Arai H; Maeda J; Takagaki K; Takayama K
    J Pharm Sci; 2012 Jul; 101(7):2372-81. PubMed ID: 22473528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Dissolution Data Integrated in Tablet Database Using Four-Layered Artificial Neural Networks.
    Takayama K; Kawai S; Obata Y; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2017; 65(10):967-972. PubMed ID: 28966281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks.
    Takagaki K; Arai H; Takayama K
    J Pharm Sci; 2010 Oct; 99(10):4201-14. PubMed ID: 20310024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent structure analysis in pharmaceutical formulations using Kohonen's self-organizing map and a Bayesian network.
    Kikuchi S; Onuki Y; Yasuda A; Hayashi Y; Takayama K
    J Pharm Sci; 2011 Mar; 100(3):964-75. PubMed ID: 21355105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests.
    Momeni M; Afkanpour M; Rakhshani S; Mehrabian A; Tabesh H
    BMC Med Inform Decis Mak; 2024 Mar; 24(1):88. PubMed ID: 38539201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of quantitative relationships between physicochemical properties of active pharmaceutical ingredients and tensile strength of tablets using a boosted tree.
    Hayashi Y; Oishi T; Shirotori K; Marumo Y; Kosugi A; Kumada S; Hirai D; Takayama K; Onuki Y
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1090-1098. PubMed ID: 29376430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method.
    Hayashi Y; Tsuji T; Shirotori K; Oishi T; Kosugi A; Kumada S; Hirai D; Takayama K; Onuki Y
    Int J Pharm; 2017 Oct; 532(1):82-89. PubMed ID: 28859939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical granulation and tablet formulation using neural networks.
    Kesavan JG; Peck GE
    Pharm Dev Technol; 1996 Dec; 1(4):391-404. PubMed ID: 9552323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks.
    Chansanroj K; Petrović J; Ibrić S; Betz G
    Eur J Pharm Sci; 2011 Oct; 44(3):321-31. PubMed ID: 21878388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Precise Prediction Method for the Properties of API-Containing Tablets Based on Data from Placebo Tablets.
    Hayashi Y; Shirotori K; Kosugi A; Kumada S; Leong KH; Okada K; Onuki Y
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent structure modeling underlying theophylline tablet formulations using a Bayesian network based on a self-organizing map clustering.
    Yasuda A; Onuki Y; Obata Y; Takayama K
    Drug Dev Ind Pharm; 2015; 41(7):1148-55. PubMed ID: 24994002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of starch-metal silicate Co-precipitates--evaluation as tablet superdisintegrant.
    Singh I; Kaur B; Juneja P
    Polim Med; 2014; 44(3):157-66. PubMed ID: 25696940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-organizing map analysis using multivariate data from theophylline tablets predicted by a thin-plate spline interpolation.
    Yasuda A; Onuki Y; Obata Y; Yamamoto R; Takayama K
    Chem Pharm Bull (Tokyo); 2013; 61(3):304-9. PubMed ID: 23449198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
    Sano S; Iwao Y; Kimura S; Noguchi S; Itai S
    Int J Pharm; 2014 Jul; 468(1-2):234-42. PubMed ID: 24709215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.